Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Kleber, F.X
Right arrow Articles by Winterhalter, M
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kleber, F.X
Right arrow Articles by Winterhalter, M
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


CPET in heart failure

F.X Klebera,*, P Waurickb and M Winterhalterb

a Charité Medical School, Director Dep. Int. Medicine, ukb academic teaching hospital, Warenerstr. 7, D 12683 Berlin, Germany
b Dep. Int. Medicine, ukb academic teaching hospital, Warenerstr. 7, D 12683 Berlin, Germany

Received 3 May 2004; accepted 24 May 2004.

* F.X. Kleber, Charité Medical School, Director Dep. Int. Medicine, ukb academic teaching hospital, Warenerstr. 7, D 12683 Berlin, Germany. Tel.: +49-30-5681-3601; fax.: +49-30-5681-3603
FXKleber{at}ukb.de

Abstract

CPET has gained wide acceptance in CHF for evaluation and quantification of symptoms, for differential diagnosis of dyspnea, for judgement of prognosis, and as a guide to therapy. In this article technical as well as pathophysiological aspects are discussed and the clinical use of CPET in CHF is outlined. Aside from measurement of VO2 new parameters like VE/VCO2 and furnish the clinician with helpful information for diagnosis and treatment.

Key Words: Exercise testing (in) heart failure • Dyspnea • Prognosis • Symptoms


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CirculationHome page
E. Hsich, E. Z. Gorodeski, R. C. Starling, E. H. Blackstone, H. Ishwaran, and M. S. Lauer
Importance of Treadmill Exercise Time as an Initial Prognostic Screening Tool in Patients With Systolic Left Ventricular Dysfunction
Circulation, June 30, 2009; 119(25): 3189 - 3197.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
L. Ingle
Prognostic value and diagnostic potential of cardiopulmonary exercise testing in patients with chronic heart failure
Eur J Heart Fail, February 1, 2008; 10(2): 112 - 118.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.